Prevalence of temporomandibular disorders in subjects affected by Parkinson disease: a systematic review and metanalysis
G Minervini, R Franco, MM Marrapodi… - Journal of Oral …, 2023 - Wiley Online Library
Abstract Introduction While Temporomandibular disorders (TMDs) are not typically
considered a primary symptom of Parkinson disease (PD), recent studies have documented …
considered a primary symptom of Parkinson disease (PD), recent studies have documented …
Neuropathic pain
L Colloca, T Ludman, D Bouhassira, R Baron… - Nature reviews Disease …, 2017 - nature.com
Neuropathic pain is caused by a lesion or disease of the somatosensory system, including
peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7–10% of the …
peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7–10% of the …
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications
Neurotransmitters serve as chemical messengers playing a crucial role in information
processing throughout the nervous system, and are essential for healthy physiological and …
processing throughout the nervous system, and are essential for healthy physiological and …
[HTML][HTML] An inflammation-centric view of neurological disease: beyond the neuron
Inflammation is a complex biological response fundamental to how the body deals with
injury and infection to eliminate the initial cause of cell injury and effect repair. Unlike a …
injury and infection to eliminate the initial cause of cell injury and effect repair. Unlike a …
Central neuropathic pain
Central neuropathic pain arises from a lesion or disease of the central somatosensory
nervous system such as brain injury, spinal cord injury, stroke, multiple sclerosis or related …
nervous system such as brain injury, spinal cord injury, stroke, multiple sclerosis or related …
[HTML][HTML] Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress
Y Shi, W Wu - BMC medicine, 2023 - Springer
Background Chronic pain conditions impose significant burdens worldwide.
Pharmacological treatments like opioids have limitations. Non-invasive non …
Pharmacological treatments like opioids have limitations. Non-invasive non …
[HTML][HTML] Exploring the journey of emodin as a potential neuroprotective agent: novel therapeutic insights with molecular mechanism of action
Emodin is an anthraquinone derivative found in the roots and bark of a variety of plants,
molds, and lichens. Emodin has been used as a traditional medication for more than 2000 …
molds, and lichens. Emodin has been used as a traditional medication for more than 2000 …
TRPA1 as a therapeutic target for nociceptive pain
D Souza Monteiro de Araujo, R Nassini… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Chronic pain affects approximatively 30–50% of the population globally.
Pathologies such as migraine, diabetic neuropathy, nerve injury and treatment with …
Pathologies such as migraine, diabetic neuropathy, nerve injury and treatment with …
[HTML][HTML] Genome-wide association study of multisite chronic pain in UK Biobank
KJA Johnston, MJ Adams, BI Nicholl, J Ward… - PLoS …, 2019 - journals.plos.org
Chronic pain is highly prevalent worldwide and represents a significant socioeconomic and
public health burden. Several aspects of chronic pain, for example back pain and a severity …
public health burden. Several aspects of chronic pain, for example back pain and a severity …